Introduction
Leishmania is a digenetic protozoan parasite that causes a spectrum of pathologies in humans that range in severity from self-healing cutaneous lesions to visceral leishmaniasis, the latter being an invariably fatal disease in the absence of drug treatment. The extracellular, flagellated promastigote stage resides in the insect vector, sandflies of the Phlebotominae subfamily, while the intracellular amastigote form inhabits the phagolysosome of macrophages and other reticuloendothelial cells within the mammalian host. There is no effective vaccine for leishmaniasis, and therefore chemotherapy is the only means available to combat the disease. Unfortunately, the current arsenal of anti-leishmanial drugs is far from ideal, principally due to host toxicity for which lack of target specificity is the chief culprit and to the acquisition of drug resistance (23, 38) . Thus, the identification and validation of new drug targets, particularly for treating visceral leishmaniasis, is imperative.
One pathway that has been clinically validated as an anti-parasitic drug target is that for polyamine biosynthesis. The polyamines, putrescine, spermidine, and spermine, are ubiquitous organic cations that play critical roles in a variety of key cellular processes, including growth, differentiation, and macromolecular synthesis (5, 29, 30, 52) . D,L-α-difluoromethylornithine 1 (DFMO), a suicide inhibitor of ornithine decarboxylase (ODC), the enzyme that catalyzes the rate limiting step in the polyamine biosynthetic pathway (37) , has shown remarkable therapeutic efficacy in treating African sleeping sickness caused by Trypanosoma brucei gambiense (2, 14, 20, 51, 55) , a protozoan parasite phylogenetically related to Leishmania. DFMO is also effective at killing other genera of protozoan parasites (1, 10, 24, 45) , including Leishmania promastigotes (32, 34, 39, 45, 50) , and studies have shown that DFMO can also inhibit short-term L. donovani infections in mice (27, 34) and hamsters (40) . Moreover, inhibitors of S-adenosylmethionine decarboxylase (ADOMETDC), the enzyme that provides the aminopropyl group for spermidine synthesis, are also effective antitrypanosomal agents (3, 8, 9, 15, 18, 54) .
The polyamine biosynthetic pathway of Leishmania consists of four enzymes;
arginase (ARG), ODC, ADOMETDC, and spermidine synthase (SPDSYN). ARG, the first enzyme of this pathway, catalyzes the conversion of arginine to ornithine.
Subsequently, ornithine is decarboxylated by ODC to form putrescine, which is then converted to spermidine through the concerted actions of ADOMETDC and SPDSYN.
Unlike mammalian cells, however, Leishmania parasites do not synthesize or make use of spermine (4, 31) .
The genes encoding the leishmanial ARG, ODC, ADOMETDC, and SPDSYN proteins have all been cloned, and a battery of conditionally lethal null mutants in L. (47, 48) . Thus, an intact polyamine biosynthetic pathway is essential for the viability and growth of Leishmania promastigotes. 
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Materials and Methods
Parasites
All genetically manipulated parasites were derived from the wild type LdBob strain of L. For growth experiments in putrescine and/or DFMO, wild type LdBob promastigotes or axenic amastigotes were seeded at 1.0 X 10 5 parasites/ml in their respective growth media, and putrescine and/or DFMO were added as specified.
Promastigotes were enumerated daily and axenic amastigotes after four days by hemacytometer.
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For limiting dilution assays to quantify parasite loads in mice, serial 4-fold dilutions of liver and spleen cell lysates were cultivated in 96-well plates in promastigote growth medium to which 10% fetal bovine serum and 200 µM putrescine were added.
Growth in individual wells was monitored after two weeks by visual inspection.
Transfections
The LdBob ∆odc knockouts were constructed using the same drug resistance 
Southern and western blot analyses
Genomic DNA from wild type and ∆odc parasites was prepared for Southern blot analysis using the DNAeasy kit (Qiagen Inc., Valencia, CA) according to the manufacturer's protocol. DNA was digested with SalI and probed with a 1.0 kb fragment of the ODC coding region using highly stringent hybridization conditions.
Parasite lysates from exponentially growing cell populations were fractionated by sodium dodecyl sulfate -polyacrylamide gel electrophoresis (35) , blotted onto either nitrocellulose or Nytran membranes (Schleicher and Schuell, Keene, NH), and western blot analysis performed according to standardized procedures (53) . The membranes were probed with polyclonal antibodies raised to the L. donovani ODC, ADOMETDC, 
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Infection of peritoneal macrophages
Macrophages were harvested five days after intraperitoneal injection of 1.2 ml of 3%
Brewer thioglycollate into Balb/C mice. harvested four weeks afterward as described (13) . Single cell suspensions of mouse organs were prepared by passage through a 70 µm cell strainer (BD Falcon), and parasitemias were then determined in 96-well microtiter plates using a standardized limiting dilution assay (13) .
Results
Expression of polyamine biosynthetic enzymes in L. donovani promastigotes and axenic amastigotes
L. donovani promastigotes are polyamine prototrophs and express the entire complement of polyamine biosynthetic enzymes (31, (47) (48) (49) . However, little is known about polyamine biosynthesis in amastigotes. As a prelude to examining the consequences of a genetic loss of polyamine biosynthesis on the ability of amastigotes to propagate within animals, the expression levels of polyamine biosynthetic proteins in
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promastigotes and axenic amastigotes was compared. Western blots of fractionated L.
donovani lysates probed with monospecific polyclonal antisera raised to ODC, ADOMETDC, and SPDSYN revealed that all three enzymes are expressed in axenic amastigotes at levels equivalent to those observed in promastigotes (Fig. 1) . These lysates were also probed with antibodies to A2, an amastigote-specific antigen (59), in order to establish authenticity of the axenic amastigote culture, and with a commercial monoclonal antibody to tubulin, a protein that is not expressed in a stage-specific fashion, as the loading control. The robust and comparable expression of ODC, ADOMETDC, and SPDSYN in both promastigotes and axenic amastigotes demonstrated that amastigotes express the requisite enzymatic machinery to convert ornithine into putrescine and spermidine.
Molecular characterization of LdBob ∆odc lines
Although we have previously reported the phenotypic characterization of ∆odc L.
donovani promastigotes, this analysis was undertaken in an avirulent L. donovani strain (31) . Thus, the ∆odc lesion was recreated in LdBob, a virulent L. donovani strain that is capable of establishing visceralizing infections in mice (19, 26) . Southern blot analysis of genomic DNA prepared from wild type and mutant parasites clearly demonstrated the allelic rearrangements that triggered the loss of ODC coding sequences in the ∆odc1 and ∆odc2 clones ( Fig. 2A) . Ethidium bromide staining indicated equal loading of chromosomal DNA on all three lanes of the Southern blot (Fig. 2B) . Loss of the wild type ODC locus in the two null mutants was corroborated by western blot analysis of 
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Nutritional phenotypes of LdBob ∆odc parasites
As anticipated, ∆odc1 and ∆odc2 promastigotes exhibited polyamine auxotrophy and, unlike wild type parasites, could not proliferate in polyamine-deficient medium (Fig. 3 ).
This polyamine auxotrophy could be circumvented genetically by complementation with a covering ODC plasmid or pharmacologically by supplying either putrescine ( amastigotes, as expected, grew robustly in polyamine-deficient medium (Fig. 3) . (Fig. 5A) , a value similar to that reported for promastigotes (28, 32) . DFMO toxicity was abrogated in the presence of 200 µM putrescine, as axenic amastigotes were completely refractory to 500 µM DFMO. DFMO was not tested against either of the two ∆odc knockout lines, because these strains do not replicate efficiently in macrophages in the absence of putrescine (Fig. 4) and lack the pharmacologic target of DFMO, or the "add-back" lines that are refractory to DFMO because of ODC overproduction (46) .
Survival of ∆odc parasites in peritoneal macrophages
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In order to demonstrate DFMO efficacy on intracellular amastigotes, peritoneal macrophages infected with wild type L. donovani were exposed to DFMO. While the parasite infection obliterated the untreated macrophage culture after 96 h, 50 µM DFMO protected the macrophage culture from destruction, and no parasites were observed by visual inspection (Fig. 5B-C) after 96 h. A control experiment demonstrated that 50 µM DMFO by itself had no obvious deleterious effect on the primary macrophages that had not been exposed to parasites (Fig. 5D) .
In vivo infections with ∆odc L. donovani
To determine the effects of a genetic deficiency of parasite ODC on virulence in an animal model, parasite burdens in both liver and spleen were assessed in Balb/c mice injected with either wild type, ∆odc1, ∆odc1[pXG-BSD-ODC], ∆odc2, or ∆odc2[pXG- (Fig. 6 ). The abilities of both the ∆odc1 and ∆odc2 to infect mice were severely diminished, and the virulence defect was rescued by episomal complementation (Fig. 6 ). The average liver and spleen parasite loads of mice infected with wild type parasites was ~2 X 10 8 parasites/g and 2 X 10 5 parasites/g, respectively ( Fig. 6A-B) . It should be noted that the absolute numbers of wild type parasites in liver and spleen on a per g basis differed by three orders of magnitude, a discrepancy typically observed for L. donovani infections (11, 21, 33, 41) . In contrast, parasitemias of mice infected with ∆odc1 or ∆odc2 parasites four weeks post-infection were ~10 restored essentially to wild type levels, whereas the parasite burdens in livers and spleens of mice infected with the ∆odc2[pXG-BSD-ODC] complemented line were also significantly higher than those of the uncomplemented parental knockout but did not reach wild type levels ( Fig. 6A-B) . These data were also corroborated in a separate experiment in which parasite burdens were ascertained by enumeration of amastigotes in Giemsa-stained liver slices. Strikingly, no parasites were detected in all six of the mice infected with the ∆odc1 parasites in this mouse experiment (data not shown).
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Discussion
Previous studies have established ODC as a valid therapeutic target in Leishmania promastigotes (32, 34, 39, 45, 50) , but the role of ODC has not been definitively established for amastigotes, the human infectious form of the parasite. The demonstration that two independent ∆odc lines were severely compromised in their abilities to establish infections in Balb/c mice provides powerful genetic evidence that ODC plays an essential housekeeping function in the amastigote stage of the parasite.
The average liver and spleen parasite loads of mice infected with ∆odc1 or ∆odc2 parasites, as assessed by limiting dilution, were six and three orders of magnitude lower, respectively, than those of wild type parasites (Fig. 6 ).
That the extremely attenuated phenotype of the ∆odc1 or ∆odc2 parasites can be ascribed to the allelic replacements at the ODC locus and not to secondary mutations was genetically confirmed by episomal rescue of the genetic lesion. Two separate "add-back" lines exhibited dramatically increased capacities compared to the knockout parental parasites to infect mouse organs at levels close to those obtained (7, 12, 16, 56) , the rate of plasmid elimination and the level of ODC expression in rodent experiments is impossible to control.
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Although no parasites were detected in the liver samples of any of the six mice infected with the ∆odc1 parasites when analyzed by visual inspection(data not shown), a separate experiment showed that each liver and spleen of mice injected with either ∆odc1 and ∆odc2 promastigotes continued to harbor several hundred persistent parasites four weeks post inoculation (Fig. 6A-B The enormous diminution in parasite burdens conferred by loss of ODC is mirrored by the infectivity differences observed between wild type and ∆odc parasites in murine peritoneal macrophages. Parasite loads in macrophages infected with the ∆odc1 or ∆odc2 null mutants were ~80% reduced over those obtained in macrophages exposed to wild type L. donovani (Fig. 4) . The infectivity deficit with each knockout was Although ODC is a validated target for African trypanosomiasis, it has been generally alleged that ODC is not a target for leishmaniaisis, presumably due to the existence of salvageable polyamines in the host phagolysosome to which the parasites would have access. DFMO toxicity toward promastigotes of several Leishmania species is well documented (32, 34, 39, 45) . Furthermore, ODC is the sole target for DFMO action in L. donovani since DFMO toxicity is completely circumvented by pharmacological supplementation of the growth medium with putrescine (32) or by overexpression of ODC from an episome (46) . However, several review articles have asserted that the amastigote stage of the parasite is generally refractory to DFMO (17, 36 ). Yet, DFMO has shown promise against experimental Leishmania infections in mice and hamsters, although in none of these experimental infections did DFMO achieve a cure. However, these rodent studies were preliminary and the time courses of drug administration limited (27, 34, 40) . Our investigations established that a ∆odc
lesion radically impaired the ability of L. donovani to sustain an infection in Balb/c mice and revealed that genetic or pharmacological impairment of ODC significantly lowered parasite loads in macrophages in vitro. These findings imply, contrary to previous speculations (17, 36) that putrescine is either not present in the phagolysosome or at least not found in sufficient amounts to sustain a leishmanial infection when de novo polyamine production is obliterated. Whether genetic lesions in other polyamine biosynthetic enzymes, ADOMETDC and SPDSYN, also negatively impact the ability of L. donovani to colonize macrophages and establish infections in rodents remains to be
examined. This will be tested by reconstruction of the ∆adometdc and ∆spdsyn lesions that have already been generated in the avirulent DI700 L. donovani strain (47, 48) in the wild type LdBob virulence background.
It is important to note that although these studies bolster ODC as a potential drug target for treating leishmaniasis, DFMO itself, the suicide inhibitor of ODC, is an unlikely "lead" candidate drug. DFMO is expensive to synthesize, binds only weakly to parasite ODC proteins (K i values for the T. brucei and L. donovani ODCs are 130 µM and 170 µM, respectively (43) , is needed in hectogram amounts to be effective against T. brucei infections, requires prolonged and multiple intravenous administrations in a hospital setting, and exhibits poor pharmacokinetics (20, 42, 44, 57) . Nevertheless, our findings implicated ODC as a valid drug target for treating visceral leishmaniasis and will hopefully spur the development of other pharmacological inhibitors of ODC in
Leishmania.
Figure Legends were each performed in triplicate (n = 6). 
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